Pharma Invest ApS: Financial statements 2024
CVR: 44073110
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Invest ApS (CVR 44073110) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -18,500 and a net result of DKK 179,023. Equity in the 2024 report amounted to DKK 538,298. The solvency ratio was 25.5%.
- Gross Profit
- DKK -18,500
- Profit/Loss
- DKK 179,023
- Equity
- DKK 538,298
- Total Assets
- DKK 2,107,018
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Invest ApS has published its interim report for the period May 24, 2023 to December 31, 2023.
About Pharma Invest ApS
Pharma Invest ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Investering for egen regning. The management consists of Mads Ulrich. The company is owned by FFC A/S. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -24,376 and a net result of DKK -1,028,115 compared with DKK 179,023 the year before. Equity in the 2025 report amounted to DKK -489,818.